Rx-TO-OTC SWITCHES REPRESENT "BIGGEST" OPPORTUNITY FOR DRUG WHOLESALERS
This article was originally published in The Tan Sheet
Executive Summary
Rx-TO-OTC SWITCHES REPRESENT "BIGGEST" OPPORTUNITY FOR DRUG WHOLESALERS and manufacturers alike to boost sales and profits amidst the current health care reform climate, Schering-Plough HealthCare Products Senior VP-Trade Development Raymond Modjeski suggested at the National Wholesale Druggists' Association's annual marketing conference in Orlando, Fla. on March 8. Pointing out that "not one Rx-to-OTC switch product has failed in the marketplace; all have captured a leading marketshare within the first couple of years," Modjeski proclaimed that "in these challenging economic times, Rx-to-OTC switches just may be your biggest opportunity for incremental sales and profits."